Previous close | 45.85 |
Open | 49.20 |
Bid | 40.65 |
Ask | 42.60 |
Strike | 150.00 |
Expiry date | 2026-06-18 |
Day's range | 45.85 - 49.20 |
Contract range | N/A |
Volume | |
Open interest | 19 |
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?